Kyntra Bio, Inc. (KYNB)
7.39
+0.31
(+4.38%)
USD |
NASDAQ |
Apr 14, 16:00
7.39
0.00 (0.00%)
After-Hours: 19:47
Kyntra Bio Shareholders Equity (Quarterly) : -30.04M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Anixa Biosciences, Inc. | 15.08M |
| GT Biopharma, Inc. | 5.787M |
| Gossamer Bio, Inc. | -122.76M |
| Monte Rosa Therapeutics, Inc. | 233.06M |
| Septerna, Inc. | 381.93M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 119.59M |
| Total Liabilities (Quarterly) | 115.12M |
| Debt to Equity Ratio | -0.6512 |
| Current Ratio | 3.388 |
| Net Debt Paydown Yield | 41.38% |